Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: Underlying biochemical and molecular events

Helicobacter

Volumn 14, Issue 3, 2009, Pages 159-171

  Kabir, Shahjahan ^a  

^a Academic Research and Information Management   (Sweden)

Author keywords

Cancer prevention; Carcinogenesis; Eradication; Gastric cancer; Helicobacter pylori

Indexed keywords

AMOXICILLIN; ASCORBIC ACID; BETA CAROTENE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 3; GELATINASE A; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; OMEPRAZOLE; PLACEBO; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SMOOTHENED PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ATROPHIC GASTRITIS; ATROPHY; BANGLADESH; CANCER INCIDENCE; CANCER MODEL; CANCER PREVENTION; CANCER RISK; CHINA; DISEASE ASSOCIATION; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; DRUG EFFICACY; EPIGENETICS; ERADICATION THERAPY; GARLIC; GENE EXPRESSION; GENE MUTATION; HELICOBACTER INFECTION; HIGH RISK POPULATION; HUMAN; INDIA; INTESTINE METAPLASIA; JAPAN; METHYLATION; MICROSATELLITE INSTABILITY; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; REMISSION; REVIEW; STOMACH ATROPHY; STOMACH CANCER; STOMACH CARCINOGENESIS; THAILAND; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; JAPAN; MODELS, ANIMAL; STOMACH NEOPLASMS;

ANIMALIA; HELICOBACTER PYLORI;

EID: 65749100406     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00677.x     Document Type: Review

References (151)

1. Garcia M, Jemal A, Ward EM, et al. Global cancer facts and figures 2007. Atlanta, GA : American Cancer Society, 2007 18.
2. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 61 : Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, France : International Agency for Research on Cancer, 1994.
3. Kabir S, Grant C, Daar AS. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma. Cancer Lett 1995 95 : 207 12.
4. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000 404 : 398 402. (Pubitemid 30164342)
5. Correa P, Piazuelo MB, Camargo MC. The future of gastric cancer prevention. Gastric Cancer 2004 7 : 9 16. (Pubitemid 38470689)
6. Ando T, Goto Y, Ishiguro K, et al. The interaction of host genetic factors and Helicobacter pylori infection. Inflammopharmacology 2007 15 : 10 4. (Pubitemid 46333879)
7. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975 2 : 58 60.
8. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 1992 52 : 6735 40. (Pubitemid 23006271)
9. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984 1 : 1311 5. (Pubitemid 14111103)
10. Kuipers EJ, Gracia-Casanova M, Peña AS, et al. Helicobacter pylori serology in patients with gastric carcinoma. Scand J Gastroenterol 1993 28 : 433 7. (Pubitemid 23116596)
11. Estevens J, Fidalgo P, Tendeiro T, et al. Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case-control study. Eur J Cancer Prev 1993 2 : 377 80.
12. Helicobacter and Cancer Collaborative Group Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001 49 : 347 53.
13. Eslick GD. Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence. World J Gastroenterol 2006 12 : 2991 9. (Pubitemid 43811074)
14. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001 345 : 784 9.
15. Hsu PI, Lai KH, Hsu PN, et al. Helicobacter pylori infection and the risk of gastric malignancy. Am J Gastroenterol 2007 102 : 725 30.
16. Huang JQ, Sridhar S, Chen T, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998 114 : 1169 79. (Pubitemid 28243902)
17. Kamangr F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinoma associated with Helicobacter pylori seropsitivity. J Natl Cancer Inst 2006 98 : 1445 52. (Pubitemid 44605589)
18. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 2007 102 : 1789 98. (Pubitemid 47206700)
19. Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994 73 : 2691 4. (Pubitemid 24166252)
20. Miwa H, Kikuchi S, Ohtaka K, et al. Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population. Diagn Microbiol Infect Dis 2000 36 : 95 9. (Pubitemid 30110562)
21. Ekström AM, Held M, Hansson LE, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001 121 : 784 91. (Pubitemid 32959388)
22. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995 55 : 2111 5.
23. Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995 87 : 1777 80.
24. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997 40 : 297 301. (Pubitemid 27145639)
25. Simán JH, Engstrand L, Berglund G, Forsgren A, Florén CH. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol 2007 42 : 933 40.
26. Miwa H, Go MF, Sato N. H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 2002 97 : 1106 12. (Pubitemid 34478107)
27. Singh K, Ghoshal UC. Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol 2006 12 : 1346 51.
28. Kumar S, Dhar A, Srinivasan S, Jain S, Rattan A, Sharma MP. Antibodies to Cag A protein are not predictive of serious gastroduodenal disease in Indian patients. Indian J Gastroenterol 1998 17 : 126 8.
29. Li L, Genta RM, Go MF, Gutierrez O, Kim JG, Graham DY. Helicobacter pylori strain and the pattern of gastritis among first-degree relatives of patients with gastric carcinoma. Helicobacter 2002 7 : 349 55. (Pubitemid 36068494)
30. Nomura AM, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 2002 186 : 1138 44. (Pubitemid 35177117)
31. Azuma T. Helicobacter pylori CagA protein variation associated with gastric cancer in Asia. J Gastroenterol 2004 39 : 97 103. (Pubitemid 38325184)
32. Agha A, Graham DY. Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand J Gastroenterol 2005 40 : 523 9. (Pubitemid 40676245)
33. Graham DY, Shiotani A. The time to eradicate gastric cancer is now. Gut 2006 54 : 735 8.
34. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000 343 : 78 85. (Pubitemid 30451850)
35. Yatsuya H, Toyoshima H, Mizoue T, et al. Family history and the risk of stomach cancer death in Japan: differences by age and gender. Int J Cancer 2002 97 : 688 94. (Pubitemid 34087811)
36. Dhillon PK, Farrow DC, Vaughan TL, et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 2001 93 : 148 52. (Pubitemid 32544602)
37. García-González MA, Lanas A, Quintero E, et al. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a nationwide multicenter study in Spain. Am J Gastroenterol 2007 102 : 1878 92. (Pubitemid 47301539)
38. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull 1998 54 : 139 50. (Pubitemid 28105322)
39. Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 1998 30 : 469 73. (Pubitemid 28479493)
40. Taché Y, Saperas E. Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1. Ann N Y Acad Sci 1992 664 : 353 68. (Pubitemid 23022863)
41. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996 87 : 2095 147. (Pubitemid 26086851)
42. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001 121 : 823 9. (Pubitemid 32959393)
43. Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002 94 : 1680 7. (Pubitemid 35446836)
44. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003 124 : 1193 201. (Pubitemid 36531795)
45. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor [alpha] and risk of gastric cancer in a Chinese population. Carcinogenesis 2005 26 : 631 6. (Pubitemid 41214153)
46. Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005 14 : 2487 93. (Pubitemid 41752706)
47. Canedo P, Castanheira-Vale AJ, Lunet N, et al. The interleukin-8-251 A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev 2008 17 : 28 32.
48. Savage SA, Hou L, Lissowska J, et al. Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev 2006 15 : 589 91.
49. Sugimoto M, Furuta T, Shirai N, et al. Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol 2007 22 : 51 9.
50. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001 36 : 696 9. (Pubitemid 33040943)
51. Zeng ZR, Hu PJ, Hu S, et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 2003 52 : 1684 9. (Pubitemid 37510386)
52. Gatti LL, Burbano RR, de Assumpção PP, Smith Mde A, Payão SL. Interleukin-1beta polymorphisms, Helicobacter pylori infection in individuals from Northern Brazil with gastric adenocarcinoma. Clin Exp Med 2004 4 : 93 8.
53. Camargo MC, Mera R, Correa P, et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006 15 : 1674 87 (Pubitemid 44497104)
54. Sung JJ, Lin SR, Ching JY, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000 119 : 7 14. (Pubitemid 30452573)
55. Zhou L, Sung JJ, Lin S, et al. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chinese Med J (Engl) 2003 116 : 11 4. (Pubitemid 36432713)
56. Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004 53 : 1244 9. (Pubitemid 39120105)
57. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000 92 : 1881 8. (Pubitemid 32036918)
58. Mera R, Fontham ET, Bravo LE, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005 54 : 1536 40. (Pubitemid 41531767)
59. Peek RM, Jr Schneider BG, Correa P. Coming unglued. Clin Cancer Res 2006 12 : 2952 4. (Pubitemid 43837336)
60. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006 98 : 974 83. (Pubitemid 44288162)
61. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004 291 : 187 94. (Pubitemid 38082812)
62. Take S, Mizuno M, Ishiki K, et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005 100 : 1037 42. (Pubitemid 40769039)
63. Kato M, Asaka M, Nakamura T, Azuma T, Tomita E, Kamoshida T. Helicobacter pylori eradication prevents the development of gastric cancer - results of a long-term retrospective study in Japan. Aliment Pharmacol Ther 2006 24 : 203 6. (Pubitemid 46058856)
64. Takenaka R, Okada H, Kato J, et al. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 2007 25 : 805 12. (Pubitemid 46434921)
65. Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001 48 : 225 9. (Pubitemid 32141848)
66. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008 372 : 392 7.
67. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006 9 : 245 53.
68. Takata S, Ito M, Yoshihara M, et al. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report. J Gastroenterol Hepatol 2007 22 : 571 6. (Pubitemid 46434988)
69. Oda T, Murakami K, Nishizono A, Kodama M, Nasu M, Fujioka T. Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene. Helicobacter 2002 7 : 143 51. (Pubitemid 34665831)
70. Hirayama F, Takagi S, Kusuhara H, Iwao E, Yokoyama Y, Ikeda Y. Induction of gastric ulcer and intestinal metaplasia in mongolian gerbils infected with Helicobacter pylori. J Gastroenterol 1996 31 : 755 7. (Pubitemid 26345549)
71. Shimizu N, Inada K, Nakanishi H, et al. Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 1999 20 : 669 76. (Pubitemid 29151306)
72. Sugiyama A, Maruta F, Ikeno T, et al. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 1998 58 : 2067 9. (Pubitemid 28232885)
73. Tokieda M, Honda S, Fujioka T, Nasu M. Effect of Helicobacter pylori infection on the N-methyl-N-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in mongolian gerbils. Carcinogenesis 1999 20 : 1261 6. (Pubitemid 29341448)
74. Nozaki K, Shimizu N, Ikehara Y, et al. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 2003 94 : 235 9. (Pubitemid 36575888)
75. Zheng Q, Chen XY, Shi Y, Xiao SD. Development of gastric adenocarcinoma in Mongolian gerbils after long-term infection with Helicobacter pylori. J Gastroenterol Hepatol 2004 19 : 1192 8. (Pubitemid 39371264)
76. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998 115 : 642 8. (Pubitemid 28397299)
77. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998 58 : 4255 9. (Pubitemid 28450020)
78. Franco AT, Israel DA, Washington MK, et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 2005 102 : 10646 51. (Pubitemid 41061608)
79. Romero-Gallo J, Harris EJ, Krishna U, Washington MK, Perez-Perez GI, Peek RM Jr. Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest 2008 88 : 328 36.
80. Elfvin A, Bölin I, Von Bothmer C, et al. Helicobacter pylori induces gastritis and intestinal metaplasia but no gastric adenocarcinoma in Mongolian gerbils. Scand J Gastroenterol 2005 40 : 1313 20. (Pubitemid 41658730)
81. Tatematsu M, Tsukamoto T, Toyoda T. Effects of eradication of Helicobacter pylori on gastric carcinogenesis in experimental models. J Gastroenterol 2007 42 : 7 9. (Pubitemid 46140356)
82. Franco AT, Johnston E, Krishna U, et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res 2008 68 : 379 87.
83. Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin - active participant or bystander in gastric carcinogenesis? Nat Rev Cancer 2006 6 : 936 46.
84. Przemeck SM, Varro A, Berry D, et al. Hypergastrinemia increases gastric epithelial susceptibility to apoptosis. Regul Pept 2008 146 : 147 56.
85. Fox JG, Rogers AB, Ihrig M, et al. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 2003 63 : 942 50. (Pubitemid 36278423)
86. Lee CW, Rickman B, Rogers AB, Ge Z, Wang TC, Fox JG. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res 2008 68 : 3540 8.
87. Cai X, Carlson J, Stoicov C, Li H, Wang TC, Houghton J. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 2005 128 : 1937 52. (Pubitemid 40824704)
88. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996 56 : 3238 43. (Pubitemid 26242970)
89. Pignatelli B, Bancel B, Estève J, et al. Inducible nitric oxide synthase, anti-oxidant enzymes and Helicobacter pylori infection in gastritis and gastric precancerous lesions in humans. Eur J Cancer Prev 1998 7 : 439 47. (Pubitemid 29030719)
90. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 1998 63 : 854 65. (Pubitemid 128588115)
91. Wang YZ, Cao YQ, Wu JN, Chen M, Cha XY. Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA. World J Gastroenterol 2005 11 : 46 50. (Pubitemid 40090134)
92. Wink DA, Ridnour LA, Hussain SP, Harris CC. The reemergence of nitric oxide and cancer. Nitric Oxide 2008 19 : 65 7.
93. Farinati F, Cardin R, Cassaro M, et al. Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev 2008 17 : 195 200.
94. Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KE. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994 35 : 317 22. (Pubitemid 24092898)
95. Tari A, Kitadai Y, Sumii M, et al. Basis of decreased risk of gastric cancer in severe atrophic gastritis with eradication of Helicobacter pylori. Dig Dis Sci 2007 52 : 232 9. (Pubitemid 46122073)
96. Coyle WJ, Sedlack RE, Nemec R, et al. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor. Am J Gastroenterol 1999 94 : 2885 9. (Pubitemid 29482751)
97. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ. Matrix metalloproteinases. Br J Surg 1997 84 : 160 6. (Pubitemid 27073454)
98. Kubben FJ, Sier CF, Schram MT, et al. Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels. Helicobacter 2007 12 : 498 504. (Pubitemid 47312391)
99. Hayden JD, Martin IG, Cawkwell L, Quirke P. The role of microsatellite instability in gastric carcinoma. Gut 1998 42 : 300 3. (Pubitemid 28212189)
100. Leung WK, Kim JJ, Kim JG, Graham DY, Sepulveda AR. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 2000 156 : 537 43. (Pubitemid 30643809)
101. Li JH, Shi X-Z, Lv S, Liu M, Xu GW. Effect of Helicobacter pylori infection on p53 expression of gastric mucosa and adenocarcinoma with microsatellite instability. World J Gastroenterol 2005 11 : 4363 6. (Pubitemid 41093955)
102. Tanaka A, Watari J, Tanabe H, et al. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Aliment Pharmacol Ther 2007 24 : 194 202.
103. Kim JJ, Tao H, Carloni E, Leung WK, Graham DY, Sepulveda AR. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 2002 123 : 542 53.
104. Park DI, Park SH, Kim SH, et al. Effect of Helicobacter pylori infection on the expression of DNA mismatch repair protein. Helicobacter 2005 10 : 179 84. (Pubitemid 40769948)
105. Fuster JJ, Sanz-González SM, Moll UM, Andrés V. Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol Med 2007 13 : 192 9. (Pubitemid 46687126)
106. Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 1997 108 : 26 34. (Pubitemid 27276510)
107. Nardone G, Staibano S, Rocco A, et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999 44 : 789 99. (Pubitemid 29244213)
108. Feng CW, Wang LD, Jiao LH, Liu B, Zheng S, Xie XJ. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2002 2 : 8. (Pubitemid 38851313)
109. Morgan C, Jenkins GJS, Ashton T, et al. Detection of p53 mutations in precancerous gastric tissues. Br J Cancer 2003 89 : 1314 9. (Pubitemid 37363423)
110. Satoh K, Kihira K, Kawata H, et al. p53 expression in the gastric mucosa before and after eradication of Helicobacter pylori. Helicobacter 2001 6 : 31 6. (Pubitemid 32601682)
111. Kodama M, Fujioka T, Murakami K, et al. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol 2005 20 : 941 6. (Pubitemid 40897179)
112. Kodama M, Murakami K, Okimoto T, Sato R, Watanabe K, Fujioka T. Expression of mutant type-p53 products in H pylori-associated chronic gastritis. World J Gastroenterol 2007 13 : 1541 6. (Pubitemid 46672662)
113. Mannick EE, Schurr JR, Zapata A, et al. Gene expression in gastric biopsies from patients infected with Helicobacter pylori. Scand J Gastroenterol 2004 39 : 1192 200. (Pubitemid 39656833)
114. Tsai CJ, Herrera-Goepfert R, Tibshirani RJ, et al. Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy. Cancer Epidemiol Biomarkers Prev 2006 15 : 272 80. (Pubitemid 43342174)
115. Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology 2001 48 : 743 51. (Pubitemid 32619675)
116. Guo XL, Wang LE, Du SY, et al. Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer. World J Gastroenterol 2003 9 : 246 9.
117. Kimura A, Tsuji S, Tsujii M, Sawaoka H, Iijima H, Kawai N. Expression of cyclooxygenase-2 and nitrotyrosine in human gastric mucosa before and after Helicobacter pylori eradication. Prostaglandins Leukot Essent Fatty Acids 2000 63 : 315 22.
118. Sung JJ, Leung WK, Minnie YYG, et al. Cyclooxygenase-2 expression in Helicobacter pylori associated premalignant and malignant gastric lesions. Am J Pathol 2000 157 : 729 35. (Pubitemid 32109365)
119. Konturek PC, Rembiasz K, Konturek SJ, et al. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig Dis Sci 2003 48 : 36 46. (Pubitemid 36232760)
120. Saukkonen K, Rintahaka J, Sivula A, et al. Cyclooxygenase-2 and gastric carcinogenesis. APMIS 2003 111 : 915 25. (Pubitemid 37352608)
121. Xu H, Chaturvedi R, Cheng Y, et al. Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 2004 64 : 8521 5. (Pubitemid 39552063)
122. Kuniyasu H, Yasui W, Yokozaki H, Tahara E. Helicobacter pylori infection and carcinogenesis of the stomach. Langenbecks Arch Surg 2000 385 : 69 74. (Pubitemid 30202931)
123. Ushijima T. Epigenetic field for cancerization. J Biochem Mol Biol 2007 40 : 142 50. (Pubitemid 46515191)
124. Nardone G, Compare D, Colibus PD, Nucci G, Rocco A. Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. Digestive Dis 2007 5 : 225 9.
125. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002 16 : 6 21. (Pubitemid 34049633)
126. Chan AO. E-cadherin in gastric cancer. World J Gastroenterol 2006 12 : 199 203. (Pubitemid 43336917)
127. Terrés AM, Pajares JM, O'Toole D, Ahern S, Kelleher D. H. pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. J Clin Pathol 1988 51 : 410 2.
128. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003 349 : 2042 54. (Pubitemid 37448928)
129. Chan AO, Lam SK, Wong BC, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003 52 : 502 6. (Pubitemid 36363400)
130. Chan AO, Peng JZ, Lam SK, et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006 55 : 463 8.
131. Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006 12 : 989 95. (Pubitemid 43259882)
132. Leung WK, Man EP, Yu J, et al. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res 2006 12 : 3216 21. (Pubitemid 43837372)
133. Perri F, Cotugno R, Piepoli A, et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol 2007 102 : 1361 71. (Pubitemid 46976302)
134. Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter 2008 13 : 35 41.
135. Miyazaki T, Murayama Y, Shinomura Y, et al. E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis. Helicobacter 2007 12 : 523 31. (Pubitemid 47312383)
136. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007 12 : 32 8. (Pubitemid 350076224)
137. Lee YC, Lin JT, Wu HM, Liu TY, Yen MF, Chiu HM. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. Cancer Epidemiol Biomarkers Prev 2007 16 : 875 85.
138. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007 56 : 772 81. (Pubitemid 46854190)
139. Fujioka T, Yoshiiwa A, Okimoto T, Kodama M, Murakami K. Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects. J Gastroenterol 2007 42 : 3 6. (Pubitemid 46140355)
140. Sugano K. Prevention of gastric cancer: urgent need to implement Helicobacter pylori eradication therapy as a primary preventive measure in Japan. J Gastroenterol 2007 42 : 1 2. (Pubitemid 46140354)
141. Leung WK, Wu MS, Kakugawa Y, et al. Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008 9 : 279 87.
142. Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008 23 : 351 65.
143. Rocco A, Nardone G. Diet, H. pylori infection and gastric cancer: evidence and controversies. World J Gastroenterol 2007 13 : 2901 12. (Pubitemid 47028879)
144. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007 10 : 75 83. (Pubitemid 46955941)
145. Yang HB, Cheng HC, Sheu BS, Hung KH, Liou MF, Wu JJ. Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. Aliment Pharmacol Ther 2007 25 : 455 61.
146. Leung WK, Ng EK, Chan FK, et al. Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial. Clin Cancer Res 2006 12 : 4766 72. (Pubitemid 44297831)
147. Niv Y, Hazazi R. Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication. Helicobacter 2008 13 : 56 61.
148. Ghiara P, Rossi M, Marchetti M, et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun 1997 65 : 4996 5002. (Pubitemid 27513542)
149. Marchetti M, Rossi M, Giannelli V, et al. Protection against Helicobacter
150. Maeda K, Yamashiro T, Minoura T, Fujioka T, Nasu M, Nishizono A. Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection. Microbiol Immunol 2002 46 : 613 20.
151. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 2007 12 : 89 102. (Pubitemid 46272562)